Psychemedics Corporation
PMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $13 | $17 | $28 | $39 |
| - Cash | $1 | $2 | $5 | $2 |
| + Debt | $1 | $2 | $4 | $5 |
| Enterprise Value | $13 | $17 | $26 | $42 |
| Revenue | $20 | $22 | $25 | $25 |
| % Growth | -10.9% | -12.4% | 1.3% | – |
| Gross Profit | $7 | $8 | $9 | $10 |
| % Margin | 36.1% | 38.1% | 36.8% | 41.2% |
| EBITDA | $0 | -$1 | $2 | $4 |
| % Margin | 1% | -3.4% | 8.8% | 15.7% |
| Net Income | -$2 | -$4 | -$1 | -$1 |
| % Margin | -9.5% | -18.8% | -4.3% | -2.7% |
| EPS Diluted | -0.32 | -0.72 | -0.19 | -0.12 |
| % Growth | 55.6% | -278.9% | -58.3% | – |
| Operating Cash Flow | $1 | -$1 | $5 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $1 | -$2 | $5 | $0 |